Outcomes after simultaneous pancreas and kidney transplantation and the discriminative ability of the c-peptide measurement pretransplant among type 1 and type 2 diabetes mellitus

Transplantation Proceedings

Volumn 42, Issue 7, 2010, Pages 2650-2652

  Chakkera, H A ^a   Bodner, J K ^a   Heilman, R L ^a   Mulligan, D C ^b   Moss, A A ^b   Mekeel, K L ^b   Mazur, M J ^a   Hamawi, K ^a   Ray, R M ^a   Beck, G L ^a   Reddy, K S ^b  

^a MAYO CLINIC HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; C PEPTIDE; CREATININE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; MYCOPHENOLIC ACID; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BODY MASS; CREATININE CLEARANCE; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY ALLOGRAFT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY PANCREAS TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE DRUG DOSE; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; C-PEPTIDE; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TISSUE DONORS;

EID: 77956474978     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.04.065     Document Type: Article

References (21)

1. A.C. Gruessner, and D.E. Sutherland Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of October 2002 Clin Transpl 41 2002
2. J.A. Light, and D.Y. Barhyte Simultaneous pancreas-kidney transplants in type I and type II diabetic patients with end-stage renal disease: similar 10-year outcomes Transplant Proc 37 2005 1283
3. J.A. Light, T.M. Sasaki, and C.B. Currier Successful long-term kidney-pancreas transplants regardless of C-peptide status or race Transplantation 71 2001 152
4. D.S. Nath, A.C. Gruessner, and R. Kandaswamy Outcomes of pancreas transplants for patients with type 2 diabetes mellitus Clin Transplant 19 2005 792
5. R.P. Singh, J. Rogers, and A.C. Farney Do pretransplant C-peptide levels influence outcomes in simultaneous kidney-pancreas transplantation? Transplant Proc 40 2008 510
6. W.T. Garvey, J.M. Olefsky, and A.H. Rubenstein Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM Correlation with urinary C-peptide excretion Diabetes 37 1988 590
7. Y. Imamura, K. Yokono, and K. Shii Plasma levels of proinsulin, insulin and C-peptide in chronic renal, hepatic and muscular disorders Jpn J Med 23 1984 3
8. L. Regeur, O.K. Faber, and C. Binder Plasma C-peptide in uraemic patients Scand J Clin Lab Invest 38 1978 771
9. C. Robaudo, I. Zavaroni, and G. Garibotto Renal metabolism of C-peptide in patients with early insulin-dependent diabetes mellitus Nephron 72 1996 395
10. T. Zilker, H. Wiesinger, and R. Ermler Concentration of C-peptide in correlation to kidney function Klin Wochenschr 55 1977 471
11. US Renal Data System Annual data report: atlas of end stage renal disease in the United States 2004 National Institues of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
12. International Diabetes Federation Diabetes atlas 2nd Ed. 2004 International Diabetes Federation
13. Diabetes Control and Complications Trial Research Group Clustering of long-term complications in families with diabetes in the diabetes control and complications trial Diabetes 46 1997 1829
14. H.J. Gjessing, L.E. Matzen, and O.K. Faber Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes Diabetologia 32 1989 305
15. F.J. Service, R.A. Rizza, and B.R. Zimmerman The classification of diabetes by clinical and C-peptide criteria A prospective population-based study Diabetes Care 20 1997 198
16. A.M. Covic, J.R. Schelling, and M. Constantiner Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients Kidney Int 58 2000 1742
17. M.E. Brier, H. Bays, and R. Sloan Pharmacokinetics of oral glyburide in subjects with noninsulin-dependent diabetes mellitus and renal failure Am J Kidney Dis 29 1997 907
18. T.Y. Wong, J.C. Chan, and C.C. Szeto Clinical and biochemical characteristics of type 2 diabetic patients on continuous ambulatory peritoneal dialysis: relationships with insulin requirement Am J Kidney Dis 34 1999 514
19. A.I. Katz, and A.H. Rubenstein Metabolism of proinsulin, insulin, and C-peptide in the rat J Clin Invest 52 1973 1113
20. A. Humar, T. Ramcharan, and R. Kandaswamy Technical failures after pancreas transplants: why grafts fail and the risk factorsa multivariate analysis Transplantation 78 2004 1188
21. P.G. Dean, Y.C. Kudva, and T.S. Larson Posttransplant diabetes mellitus after pancreas transplantation Am J Transplant 8 2008 175